VIRPAX PHARMACEUTICALS, INC.

Profile

Company Names

VIRPAX PHARMACEUTICALS, INC.

Addresses

1055 WESTLAKES DRIVE, SUITE 300, BERWYN, PA 19312

101 LINDENWOOD DR., SUITE 225, MALVERN, PA 19355

Phone Numbers

(610) 727-4597
561-362-9595

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$3,879,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-07-05 
$2,500,000.00 
$2,500,000.00 
$0.00 
Debt 
1
2018-02-08 
$1,379,000.00 
$3,000,000.00 
$1,621,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERALD 
 
BRUCE 
EXECUTIVE OFFICER, DIRECTOR
VIRPAX PHARMACEUTICALS, INC.
JATINDER 
 
DHALIWAL 
DIRECTOR
VIRPAX PHARMACEUTICALS, INC.
KATHARYN 
 
FIELD 
DIRECTOR
VIRPAX PHARMACEUTICALS, INC.   |  ISPECIMEN INC.
ERIC 
 
FLOYD 
DIRECTOR
SCILEX PHARMACEUTICALS, INC   |  SCILEX PHARMACEUTICALS INC.   |  VIRPAX PHARMACEUTICALS, INC.
JEFFREY 
 
GUDIN 
EXECUTIVE OFFICER, DIRECTOR
VIRPAX PHARMACEUTICALS, INC.
GARY 
 
HERMAN 
DIRECTOR
XTRACTION SERVICES INC.   |  XS FINANCIAL INC.   |  VIRPAX PHARMACEUTICALS, INC.
THANI 
 
JAMBULINGAM 
DIRECTOR
VIRPAX PHARMACEUTICALS, INC.
ANTHONY 
 
MACK 
EXECUTIVE OFFICER, DIRECTOR
SCILEX PHARMACEUTICALS INC.   |  FREEDOM TELECOM SERVICES, INC.   |  VIRPAX PHARMACEUTICALS, INC.
SHEILA 
 
MATHIAS 
EXECUTIVE OFFICER
VIRPAX PHARMACEUTICALS, INC.
JERROLD 
 
SENDROW 
DIRECTOR
SCILEX PHARMACEUTICALS INC.   |  VIRPAX PHARMACEUTICALS, INC.
VINAY 
 
SHAH 
EXECUTIVE OFFICER
ARAVIVE BIOLOGICS, INC.   |  TMRW LIFE SCIENCES, INC.   |  VIRPAX PHARMACEUTICALS, INC.   |  RAD AI, INC.   |  ADIAL PHARMACEUTICALS, INC.
VANILA 
M. 
SINGH 
DIRECTOR
VIRPAX PHARMACEUTICALS, INC.   |  NMP ACQUISITION CORP.
JUDY 
 
SU 
DIRECTOR
VIRPAX PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-07-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2024-07-05 
2018-04-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#